MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202527070993 A) filed by Shanghai Henlius Biotech Inc.; Shanghai Henlius Biopharmaceutical Co. Ltd.; and Shanghai Henlius Biologics Co. Ltd., Shanghai, on July 25, for 'anti pdl1 antibodies and methods of use.'
Inventor(s) include Xue Jie; Xu Wenfeng; Jiang Wei Dong; Lin Pei Hua; and Issafras Hassan.
The application for the patent was published on Nov. 7, under issue no. 45/2025.
According to the abstract released by the Intellectual Property India: "Provided are antibodies and antibody derivatives that bind to PDL1 and methods of using the same. The antibody or antibody derivative comprises a single domain antibody that binds to PDL1."
The patent a...